Research ArticleClinical Studies

Interval Between Cancer Diagnosis and Radiotherapy – An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer

DIRK RADES, RAPHA HAUS, STEFAN JANSSEN and STEVEN E. SCHILD
In Vivo March 2020, 34 (2) 767-770; DOI: https://doi.org/10.21873/invivo.11836

Article Information

vol. 34 no. 2 767-770
DOI 
https://doi.org/10.21873/invivo.11836
PMID 
32111782
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received November 11, 2019
  • Revision received November 19, 2019
  • Accepted November 25, 2019
  • Published online February 28, 2020.
Copyright & License 
Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. DIRK RADES1⇑,
  2. RAPHA HAUS1,
  3. STEFAN JANSSEN1,2 and
  4. STEVEN E. SCHILD3
  1. 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  2. 2Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany
  3. 3Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
  1. Correspondence to: Dirk Rades, Department of Radiation Oncology, University of Lübeck, Lübeck, Ratzeburger Allee 160, 23562 Lübeck, Germany. Tel: +49 45150045401, Fax: +49 45150045404, e-mail: rades.dirk{at}gmx.net
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Interval Between Cancer Diagnosis and Radiotherapy – An Independent Prognostic Factor of Survival in Patients Irradiated for Bone Metastases from Kidney Cancer
DIRK RADES, RAPHA HAUS, STEFAN JANSSEN, STEVEN E. SCHILD
In Vivo Mar 2020, 34 (2) 767-770; DOI: 10.21873/invivo.11836
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords